Novelos Therapeutics Provides Product Pipeline Update

To Begin I-124-CLR1404 (LIGHT) Phase 2 Imaging Trial in Brain Cancer in Early 2014

Evaluating I-131-CLR1404 (HOT) Potential Phase 2 Indications and Trial Designs

To File CLR1502 (GLOW2) IND for Intraoperative Tumor Margin Illumination by End 2013

May 16, 2013, 08:30 ET from Novelos Therapeutics, Inc.

$countyNameToPathMap.put("sp